Esposito Pamela (CIK 1744425) reported 22 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-05-19). Recent activity: Buy KYMR (1,000 shares), Buy KYMR (2,500 shares), Sell KYMR (700 shares), Sell KYMR (600 shares), Sell KYMR (1,200 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-05-19 | Kymera Therapeutics, Inc. (KYMR) | Director | Buy | 1,000 | $31,200 |
| 2026-03-20 | Kymera Therapeutics, Inc. (KYMR) | Director | Buy | 2,500 | $122,750 |
| 2026-03-20 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 700 | $54,397 |
| 2026-03-20 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 600 | $47,544 |
| 2026-03-20 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 1,200 | $95,928 |
| 2026-02-20 | Kymera Therapeutics, Inc. (KYMR) | Director | Buy | 2,500 | $122,750 |
| 2026-02-20 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 1,900 | $165,414 |
| 2026-02-20 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 600 | $52,860 |
| 2026-01-20 | Kymera Therapeutics, Inc. (KYMR) | Director | Buy | 3,000 | $93,600 |
| 2026-01-20 | Kymera Therapeutics, Inc. (KYMR) | Director | Buy | 2,500 | $122,750 |
| 2026-01-20 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 400 | $26,672 |
| 2026-01-20 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 4,900 | $333,151 |
| 2026-01-20 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 200 | $13,704 |
| 2025-12-17 | Kymera Therapeutics, Inc. (KYMR) | Director | Buy | 12,563 | $616,843 |
| 2025-12-17 | Kymera Therapeutics, Inc. (KYMR) | Director | Buy | 12,000 | $332,040 |
| 2025-12-17 | Kymera Therapeutics, Inc. (KYMR) | Director | Buy | 3,000 | $93,600 |
| 2025-12-17 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 14,505 | $1.2M |
| 2025-12-17 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 7,959 | $655,344 |
| 2025-12-17 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 4,099 | $342,062 |
| 2025-12-17 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 1,000 | $84,070 |
| 2025-06-03 | Kymera Therapeutics, Inc. (KYMR) | Director | Buy | 5,000 | $147,750 |
| 2025-06-03 | Kymera Therapeutics, Inc. (KYMR) | Director | Sell | 5,000 | $245,200 |
Source: SEC Form 4 filings · as of 2026-05-19